Presentations included: Genetics Primer & Clinical Updates by Linford Williams, MS, LGC; Genetics and Women's
Health: Seeing and Foreseeing the Ethical Challenges Ahead by Ruth Farrell, MD, MA; Preimplantation
Genetic Screening and Diagnosis: What You Need to Know by Marissa Coleridge, MS, LGC; Evolution of Prenatal
Genetic Screening and Testing: NIPT and Beyond by Jeff Chapa, MD, MBA; Promises and Pitfalls of Prenatal Whole Exome Sequencing by Amanda Kalan, MD; Fertility Preservation and Cancer: Survivors, Previvors, and the Newly Diagnosed by Rebecca Flyckt, MD; Improving Access to Cancer Genetics via Telegenetics by Ryan Noss, MS, LGC; Breast Cancer: Management of Moderate Penetrance Predisposition Genes by Holly Pederson, MD; Use of Hormonal and Non-hormonal Therapies in Breast Cancer Survivors and Women at High
Risk for Breast / Gyn Cancers by Holly Thacker, MD;
Addressing Commonly Asked Patient Questions about Genetics by Rebekah Moore, MS, LGC, Christina Rigelsky, MS, LGC and Allison Schreiber, MS, LGC; and a panel discussion on
Genetic Testing Reimbursement featuring Bruce Rogen, MD, MPH and John Yao, MD, MBA, MPH, which was moderated by Daniel Sullivan, MD..
Plenary
Address: Andreas Meyer - Lindenberg Central Institute of Mental
Health, Department of Psychiatry and Psychotherapy, University of Heidelberg / Medical Faculty Mannheim, Germany Neural mechanisms of
genetic and environmental
risk for mental disorders
Plenary
Address: Mary - Anne Enoch Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of
Health, Bethesda, Maryland, USA A multi-directional approach to the detection of
genetic risk for alcohol dependence
Her
address, «A New Medical Research Model: Advancing Human and Animal
Health Humanely,» will detail the concept of a new research model predicated on a meaningful commitment by both medical and veterinary researchers to work cooperatively together to
address disease and disorders in humans and animals — evaluating
genetic and environmental
risk factors, sensitive diagnostic indicators and novel therapies.
Recent breakthroughs in
genetic testing are helping people pro-actively
address potential
health risks — but if you're shopping for life insurance, you may want to hold off on
genetic testing until after you apply.